Melanotan II
Broad-Spectrum Melanocortin Agonist
Melanotan II is a cyclic analogue of alpha-MSH that broadly activates melanocortin receptors — MC1R (tanning/pigmentation), MC3R and MC4R (sexual arousal, energy balance), and MC5R (exocrine glands). Its broad receptor profile is the source of both its wide-ranging research utility and its complex side effect landscape.
At a Glance
Melanotan II's breadth of receptor activation means no single research application defines it — it is simultaneously a tanning research tool, a sexual function research tool, an appetite suppression tool, and a melanocortin cascade characterization tool.
It was the precursor to both PT-141 (which isolated and amplified the MC3R/MC4R sexual function mechanism) and Melanotan I (which isolated the MC1R tanning mechanism) — meaning its primary research value today is often as the non-selective baseline from which selective analogues are compared.
Appetite suppression via MC4R activation is also a studied effect — connecting it to the broader melanocortin role in energy homeostasis alongside MC4R's central role in GLP-1 downstream signaling.
This compound operates through several converging biological pathways, which helps explain the breadth of effects observed across different tissue and metabolic models.
MC1R Tanning
Activates melanocytes via MC1R to drive eumelanin synthesis — UV-independent pigmentation and photoprotection.
MC3R/MC4R Sexual Function
Activates hypothalamic and limbic melanocortin receptors governing sexual motivation and arousal — the mechanism isolated in PT-141.
MC4R Appetite Suppression
Central MC4R activation reduces appetite and food intake — connecting melanocortin research to metabolic physiology.
Broad MCR Cascade
Simultaneous MC1R, MC3R, MC4R, MC5R activation provides a complete melanocortin cascade research model.
Preclinical and clinical models have investigated this compound across a wide range of physiological contexts and tissue types.
- Melanogenesis and tanning mechanism — UV-independent eumelanin induction
- Sexual function research — precursor compound to PT-141
- MC4R appetite suppression — melanocortin role in energy balance
- Melanocortin receptor pharmacology — non-selective baseline for selective analogue comparison
- Erection and arousal models — original dataset from which PT-141 was derived
- Photoprotection — comparison vs Melanotan I selectivity
- Skin pigmentation disorders — melanocyte biology research
Melanotan II's primary research value is as the broad-spectrum reference point for melanocortin research — the parent compound from which all selective analogues are derived and compared.Compound Comparison
Melanotan II sits between its two selective analogues — understanding it contextualizes both of them.
| Aspect | Melanotan II | Melanotan I | PT-141 |
|---|---|---|---|
| Receptor Profile | MC1, MC3, MC4, MC5 | MC1R selective | MC3R, MC4R selective |
| Tanning | Yes | Yes (primary effect) | Minimal |
| Sexual Arousal | Yes | None | Yes (primary effect) |
| FDA Status | Not approved | Approved (Scenesse) | Approved (Vyleesi) |
| Research Role | Broad-spectrum baseline | Photoprotection model | Sexual function model |
The following reflects findings from published preclinical and clinical safety assessments where available.
Broad MCR profile — useful when studying the full melanocortin cascade simultaneously
Historical research depth — most-studied melanocortin peptide; extensive characterization data
Non-selective side effects — nausea, spontaneous erections, appetite suppression make it less ideal than selective analogues for most modern research
Not approved — unlike its derivatives MT-I and PT-141; regulatory status reflects its non-selectivity
This overview is strictly educational and based on publicly available scientific literature as of 2026. It does not constitute medical advice. All Helixera Labs products are for laboratory research use only. Not for human or veterinary use. · Helixera Labs LLC © 2026